0001626547-17-000001.txt : 20170713 0001626547-17-000001.hdr.sgml : 20170713 20170713141716 ACCESSION NUMBER: 0001626547-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170713 DATE AS OF CHANGE: 20170713 EFFECTIVENESS DATE: 20170713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innocrin Pharmaceuticals Holdings, LLC CENTRAL INDEX KEY: 0001626547 IRS NUMBER: 471305552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-290642 FILM NUMBER: 17963270 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 240 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-237-9536 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 240 CITY: DURHAM STATE: NC ZIP: 27703 D 1 primary_doc.xml X0707 D LIVE 0001626547 Innocrin Pharmaceuticals Holdings, LLC 4505 EMPEROR BOULEVARD SUITE 300 DURHAM NC NORTH CAROLINA 27703 919-237-9536 DELAWARE None None Limited Liability Company true 2014 Fred Eshelman 4505 Emperor Boulevard Suite 300 Durham NC NORTH CAROLINA 27703 Executive Officer Director Douglas Reed 4505 Emperor Boulevard Suite 300 Durham NC NORTH CAROLINA 27703 Director Richard Kent 4505 Emperor Boulevard Suite 300 Durham NC NORTH CAROLINA 27703 Director S. Edward Torres 4505 Emperor Boulevard Suite 240 Durham NC NORTH CAROLINA 27703 Director Andrew von Eschenbach 4505 Emperor Boulevard Suite 300 Durham NC NORTH CAROLINA 27703 Director Kristopher Wood 4505 Emperor Boulevard Suite 300 Durham NC NORTH CAROLINA 27703 Director Robert Schotzinger 4505 Emperor Boulevard Suite 300 Durham NC NORTH CAROLINA 27703 Director Charles Osborne 4505 Emperor Boulevard Suite 300 Durham NC NORTH CAROLINA 27703 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-07-11 false true true false 0 13000000 6000000 7000000 false 7 0 0 0 false Innocrin Pharmaceuticals Holdings, LLC /s/ Fred Eshelman Fred Eshelman Chief Executive Officer 2017-07-13